Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004
Published online before print December 9, 2004, doi: 10.1161/01.RES.0000152969.42117.ca
A more recent version of this article appeared on February 4, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/2/234    most recent
01.RES.0000152969.42117.cav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katori, T.
Right arrow Articles by Paolocci, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katori, T.
Right arrow Articles by Paolocci, N.
Related Collections
Right arrow Contractile function
Right arrow Congestive
Right arrow Animal models of human disease
Right arrow Receptor pharmacology

Submitted on March 30, 2004
Revised on November 1, 2004
Accepted on November 30, 2004

Calcitonin Gene-Related Peptide In Vivo Positive Inotropy Is Attributable to Regional Sympatho-Stimulation and Is Blunted in Congestive Heart Failure

Tatsuo Katori ; Donald B. Hoover ; Jeffrey L. Ardell ; Robert H. Helm ; Diego F. Belardi ; Carlo G. Tocchetti ; Paul R. Forfia ; David A. Kass ; and Nazareno Paolocci *

From Division of Cardiology (T.K., R.H.H., D.F.B., C.G.T., P.R.F., D.A.K., N.P.), Department of Medicine, Johns Hopkins Medical Institutions; Baltimore, Md; and the Department of Pharmacology (D.B.H., J.L.A.), College of Medicine, East Tennessee State University, Johnson City.

* To whom correspondence should be addressed. E-mail: npaoloc1{at}jhmi.edu.

Calcitonin gene-related peptide (CGRP) is a nonadrenergic/noncholinergic (NANC) peptide with vasodilatative/inotropic action that may benefit the failing heart. However, precise mechanisms for its in vivo inotropic action remain unclear. To assess this, dogs with normal or failing (sustained tachypacing) hearts were instrumented for pressure-dimension analysis. In control hearts, CGRP (20 pmol/kg per minute) enhanced cardiac contractility (eg, +33±4.2% in end-systolic elastance) and lowered afterload (-14.2±2% in systemic resistance, both P<0.001). The inotropic response was markedly blunted by heart failure (+6.5±2%; P<0.001 versus control), whereas arterial dilation remained unaltered (-19.3±5%). CGRP-positive inotropy was not attributable to reflex activation because similar changes were observed in the presence of a ganglionic blocker. However, it was fully prevented by the {beta}-receptor antagonist (timolol), identifying a dominant role of sympatho-stimulatory signaling. In control hearts, myocardial interstitial norepinephrine assessed by microdialysis almost doubled in response to CGRP infusion, whereas systemic plasma levels were unchanged. In addition, CGRP receptors were not observed in ventricular myocardium but were prominent in coronary arteries and the stellate ganglia. Ventricular myocytes isolated from normal and failing hearts displayed no inotropic response to CGRP, further supporting indirect sympatho-stimulation as the primary in vivo mechanism. In contrast, the peripheral vasodilatative capacity of CGRP was similar in femoral vascular rings from normal and failing hearts in dogs. Thus, CGRP-mediated positive inotropy is load-independent but indirect and attributable to myocardial sympathetic activation rather than receptor-coupled stimulation in canine hearts. This mechanism is suppressed in heart failure, so that afterload reduction accounts for CGRP-enhanced function in this setting.


Key words: calcitonin gene-related peptide • sympathetic efferent fibers • heart failure • norepinephrine • contractility




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Paolocci and D. A. Wink
The shy Angeli and his elusive creature: the HNO route to vasodilation
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1217 - H1220.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. P. Regan, G. L. Stump, S. A. Kane, and J. J. Lynch Jr.
Calcitonin Gene-Related Peptide Receptor Antagonism Does Not Affect the Severity of Myocardial Ischemia during Atrial Pacing in Dogs with Coronary Artery Stenosis
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 571 - 578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. H. Kunz, M. Scott, L. M. Ittner, J. A. Fischer, W. Born, and J. Vogel
Calcitonin gene-related peptide-evoked sustained tachycardia in calcitonin receptor-like receptor transgenic mice is mediated by sympathetic activity
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2155 - H2160.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Kimura, M. Ieda, H. Kanazawa, T. Yagi, M. Tsunoda, S.-i. Ninomiya, H. Kurosawa, K. Yoshimi, H. Mochizuki, K. Yamazaki, et al.
Cardiac Sympathetic Rejuvenation: A Link Between Nerve Function and Cardiac Hypertrophy
Circ. Res., June 22, 2007; 100(12): 1755 - 1764.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. R. Forfia, M. Lee, R. S. Tunin, M. Mahmud, H. C. Champion, and D. A. Kass
Acute Phosphodiesterase 5 Inhibition Mimics Hemodynamic Effects of B-Type Natriuretic Peptide and Potentiates B-Type Natriuretic Peptide Effects in Failing But Not Normal Canine Heart
J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1079 - 1088.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. G. Tocchetti, W. Wang, J. P. Froehlich, S. Huke, M. A. Aon, G. M. Wilson, G. Di Benedetto, B. O'Rourke, W. D. Gao, D. A. Wink, et al.
Nitroxyl Improves Cellular Heart Function by Directly Enhancing Cardiac Sarcoplasmic Reticulum Ca2+ Cycling
Circ. Res., January 5, 2007; 100(1): 96 - 104.
[Abstract] [Full Text] [PDF]